nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—ALB—primary biliary cirrhosis	0.324	1	CbGaD
Fluoxetine—CYP2B6—Colchicine—primary biliary cirrhosis	0.114	0.338	CbGbCtD
Fluoxetine—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0693	0.206	CbGbCtD
Fluoxetine—CYP2C9—Colchicine—primary biliary cirrhosis	0.0603	0.179	CbGbCtD
Fluoxetine—ABCB1—Colchicine—primary biliary cirrhosis	0.0585	0.173	CbGbCtD
Fluoxetine—CYP3A4—Colchicine—primary biliary cirrhosis	0.0351	0.104	CbGbCtD
Fluoxetine—ORM1—bile—primary biliary cirrhosis	0.00641	0.417	CbGeAlD
Fluoxetine—ORM1—gall bladder—primary biliary cirrhosis	0.00178	0.116	CbGeAlD
Fluoxetine—ALB—gall bladder—primary biliary cirrhosis	0.00156	0.102	CbGeAlD
Fluoxetine—Amnesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00076	0.00267	CcSEcCtD
Fluoxetine—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000754	0.00265	CcSEcCtD
Fluoxetine—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000754	0.00265	CcSEcCtD
Fluoxetine—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000751	0.00264	CcSEcCtD
Fluoxetine—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000751	0.00264	CcSEcCtD
Fluoxetine—SIGMAR1—smooth muscle tissue—primary biliary cirrhosis	0.00075	0.0489	CbGeAlD
Fluoxetine—Dehydration—Colchicine—primary biliary cirrhosis	0.000739	0.0026	CcSEcCtD
Fluoxetine—Arthritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000735	0.00258	CcSEcCtD
Fluoxetine—Arthritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000735	0.00258	CcSEcCtD
Fluoxetine—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.000729	0.00256	CcSEcCtD
Fluoxetine—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.000729	0.00256	CcSEcCtD
Fluoxetine—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000714	0.00251	CcSEcCtD
Fluoxetine—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000714	0.00251	CcSEcCtD
Fluoxetine—Diplopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000714	0.00251	CcSEcCtD
Fluoxetine—Diplopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000714	0.00251	CcSEcCtD
Fluoxetine—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00247	CcSEcCtD
Fluoxetine—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.000703	0.00247	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.000701	0.00246	CcSEcCtD
Fluoxetine—Muscular weakness—Colchicine—primary biliary cirrhosis	0.000701	0.00246	CcSEcCtD
Fluoxetine—Face oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.00069	0.00242	CcSEcCtD
Fluoxetine—Face oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.00069	0.00242	CcSEcCtD
Fluoxetine—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.000664	0.00233	CcSEcCtD
Fluoxetine—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.000664	0.00233	CcSEcCtD
Fluoxetine—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000659	0.00232	CcSEcCtD
Fluoxetine—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000659	0.00232	CcSEcCtD
Fluoxetine—Pancytopenia—Colchicine—primary biliary cirrhosis	0.000652	0.00229	CcSEcCtD
Fluoxetine—Orthostatic hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000652	0.00229	CcSEcCtD
Fluoxetine—Orthostatic hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000652	0.00229	CcSEcCtD
Fluoxetine—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000645	0.00227	CcSEcCtD
Fluoxetine—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000645	0.00227	CcSEcCtD
Fluoxetine—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00222	CcSEcCtD
Fluoxetine—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000632	0.00222	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00063	0.00221	CcSEcCtD
Fluoxetine—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00063	0.00221	CcSEcCtD
Fluoxetine—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00217	CcSEcCtD
Fluoxetine—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00217	CcSEcCtD
Fluoxetine—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00217	CcSEcCtD
Fluoxetine—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00217	CcSEcCtD
Fluoxetine—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00217	CcSEcCtD
Fluoxetine—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.000617	0.00217	CcSEcCtD
Fluoxetine—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000605	0.00213	CcSEcCtD
Fluoxetine—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000605	0.00213	CcSEcCtD
Fluoxetine—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000601	0.00211	CcSEcCtD
Fluoxetine—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000601	0.00211	CcSEcCtD
Fluoxetine—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.0006	0.00211	CcSEcCtD
Fluoxetine—Stomatitis—Colchicine—primary biliary cirrhosis	0.000597	0.0021	CcSEcCtD
Fluoxetine—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000594	0.00209	CcSEcCtD
Fluoxetine—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000594	0.00209	CcSEcCtD
Fluoxetine—Haematuria—Colchicine—primary biliary cirrhosis	0.000584	0.00205	CcSEcCtD
Fluoxetine—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00203	CcSEcCtD
Fluoxetine—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000577	0.00203	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00202	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000574	0.00202	CcSEcCtD
Fluoxetine—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00057	0.002	CcSEcCtD
Fluoxetine—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00057	0.002	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000563	0.00198	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000563	0.00198	CcSEcCtD
Fluoxetine—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000562	0.00197	CcSEcCtD
Fluoxetine—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000562	0.00197	CcSEcCtD
Fluoxetine—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000559	0.00196	CcSEcCtD
Fluoxetine—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000559	0.00196	CcSEcCtD
Fluoxetine—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000554	0.00195	CcSEcCtD
Fluoxetine—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000554	0.00195	CcSEcCtD
Fluoxetine—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.000549	0.00193	CcSEcCtD
Fluoxetine—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.000549	0.00193	CcSEcCtD
Fluoxetine—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000547	0.00192	CcSEcCtD
Fluoxetine—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000543	0.00191	CcSEcCtD
Fluoxetine—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000543	0.00191	CcSEcCtD
Fluoxetine—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000541	0.0019	CcSEcCtD
Fluoxetine—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000541	0.0019	CcSEcCtD
Fluoxetine—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00054	0.0019	CcSEcCtD
Fluoxetine—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00054	0.0019	CcSEcCtD
Fluoxetine—Jaundice—Ursodeoxycholic acid—primary biliary cirrhosis	0.000537	0.00189	CcSEcCtD
Fluoxetine—Jaundice—Chenodeoxycholic acid—primary biliary cirrhosis	0.000537	0.00189	CcSEcCtD
Fluoxetine—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00188	CcSEcCtD
Fluoxetine—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00188	CcSEcCtD
Fluoxetine—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00188	CcSEcCtD
Fluoxetine—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000535	0.00188	CcSEcCtD
Fluoxetine—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.000528	0.00185	CcSEcCtD
Fluoxetine—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.000528	0.00185	CcSEcCtD
Fluoxetine—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000525	0.00184	CcSEcCtD
Fluoxetine—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000525	0.00184	CcSEcCtD
Fluoxetine—ORM1—liver—primary biliary cirrhosis	0.000521	0.034	CbGeAlD
Fluoxetine—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000519	0.00182	CcSEcCtD
Fluoxetine—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000519	0.00182	CcSEcCtD
Fluoxetine—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00182	CcSEcCtD
Fluoxetine—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000516	0.00182	CcSEcCtD
Fluoxetine—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000497	0.00175	CcSEcCtD
Fluoxetine—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000497	0.00175	CcSEcCtD
Fluoxetine—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000495	0.00174	CcSEcCtD
Fluoxetine—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000495	0.00174	CcSEcCtD
Fluoxetine—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000494	0.00174	CcSEcCtD
Fluoxetine—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000494	0.00174	CcSEcCtD
Fluoxetine—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00172	CcSEcCtD
Fluoxetine—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00172	CcSEcCtD
Fluoxetine—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000487	0.00171	CcSEcCtD
Fluoxetine—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000487	0.00171	CcSEcCtD
Fluoxetine—Alopecia—Colchicine—primary biliary cirrhosis	0.000486	0.00171	CcSEcCtD
Fluoxetine—Malnutrition—Colchicine—primary biliary cirrhosis	0.000479	0.00168	CcSEcCtD
Fluoxetine—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000476	0.00167	CcSEcCtD
Fluoxetine—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000476	0.00167	CcSEcCtD
Fluoxetine—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000461	0.00162	CcSEcCtD
Fluoxetine—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000461	0.00162	CcSEcCtD
Fluoxetine—Muscle spasms—Colchicine—primary biliary cirrhosis	0.00046	0.00162	CcSEcCtD
Fluoxetine—ALB—liver—primary biliary cirrhosis	0.000457	0.0298	CbGeAlD
Fluoxetine—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000443	0.00156	CcSEcCtD
Fluoxetine—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000443	0.00156	CcSEcCtD
Fluoxetine—Anaemia—Colchicine—primary biliary cirrhosis	0.000442	0.00156	CcSEcCtD
Fluoxetine—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000441	0.00155	CcSEcCtD
Fluoxetine—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000441	0.00155	CcSEcCtD
Fluoxetine—SIGMAR1—liver—primary biliary cirrhosis	0.000441	0.0287	CbGeAlD
Fluoxetine—Angioedema—Colchicine—primary biliary cirrhosis	0.000437	0.00154	CcSEcCtD
Fluoxetine—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000437	0.00153	CcSEcCtD
Fluoxetine—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000437	0.00153	CcSEcCtD
Fluoxetine—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00151	CcSEcCtD
Fluoxetine—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00043	0.00151	CcSEcCtD
Fluoxetine—Leukopenia—Colchicine—primary biliary cirrhosis	0.000429	0.00151	CcSEcCtD
Fluoxetine—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00149	CcSEcCtD
Fluoxetine—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000424	0.00149	CcSEcCtD
Fluoxetine—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000422	0.00148	CcSEcCtD
Fluoxetine—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000422	0.00148	CcSEcCtD
Fluoxetine—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000418	0.00147	CcSEcCtD
Fluoxetine—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000418	0.00147	CcSEcCtD
Fluoxetine—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000416	0.00146	CcSEcCtD
Fluoxetine—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000416	0.00146	CcSEcCtD
Fluoxetine—HTR2A—epithelium—primary biliary cirrhosis	0.000415	0.027	CbGeAlD
Fluoxetine—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00145	CcSEcCtD
Fluoxetine—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00145	CcSEcCtD
Fluoxetine—Arthralgia—Colchicine—primary biliary cirrhosis	0.000408	0.00143	CcSEcCtD
Fluoxetine—Myalgia—Colchicine—primary biliary cirrhosis	0.000408	0.00143	CcSEcCtD
Fluoxetine—HTR2A—smooth muscle tissue—primary biliary cirrhosis	0.0004	0.026	CbGeAlD
Fluoxetine—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000399	0.0014	CcSEcCtD
Fluoxetine—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000399	0.0014	CcSEcCtD
Fluoxetine—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000398	0.0014	CcSEcCtD
Fluoxetine—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000398	0.0014	CcSEcCtD
Fluoxetine—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00138	CcSEcCtD
Fluoxetine—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000393	0.00138	CcSEcCtD
Fluoxetine—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00136	CcSEcCtD
Fluoxetine—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00136	CcSEcCtD
Fluoxetine—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00136	CcSEcCtD
Fluoxetine—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00136	CcSEcCtD
Fluoxetine—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00136	CcSEcCtD
Fluoxetine—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000386	0.00136	CcSEcCtD
Fluoxetine—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00135	CcSEcCtD
Fluoxetine—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000385	0.00135	CcSEcCtD
Fluoxetine—Shock—Colchicine—primary biliary cirrhosis	0.000384	0.00135	CcSEcCtD
Fluoxetine—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000383	0.00134	CcSEcCtD
Fluoxetine—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00134	CcSEcCtD
Fluoxetine—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00038	0.00134	CcSEcCtD
Fluoxetine—Skin disorder—Colchicine—primary biliary cirrhosis	0.00038	0.00133	CcSEcCtD
Fluoxetine—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00133	CcSEcCtD
Fluoxetine—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000378	0.00133	CcSEcCtD
Fluoxetine—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000375	0.00132	CcSEcCtD
Fluoxetine—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000375	0.00132	CcSEcCtD
Fluoxetine—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00131	CcSEcCtD
Fluoxetine—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.000373	0.00131	CcSEcCtD
Fluoxetine—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000371	0.00131	CcSEcCtD
Fluoxetine—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000371	0.00131	CcSEcCtD
Fluoxetine—CYP2C19—liver—primary biliary cirrhosis	0.000368	0.024	CbGeAlD
Fluoxetine—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00129	CcSEcCtD
Fluoxetine—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00129	CcSEcCtD
Fluoxetine—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00129	CcSEcCtD
Fluoxetine—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00129	CcSEcCtD
Fluoxetine—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00129	CcSEcCtD
Fluoxetine—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000366	0.00129	CcSEcCtD
Fluoxetine—Hypotension—Colchicine—primary biliary cirrhosis	0.000365	0.00128	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00128	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00128	CcSEcCtD
Fluoxetine—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000362	0.00127	CcSEcCtD
Fluoxetine—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000362	0.00127	CcSEcCtD
Fluoxetine—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00126	CcSEcCtD
Fluoxetine—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00126	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000356	0.00125	CcSEcCtD
Fluoxetine—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000354	0.00124	CcSEcCtD
Fluoxetine—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000354	0.00124	CcSEcCtD
Fluoxetine—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00123	CcSEcCtD
Fluoxetine—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000349	0.00123	CcSEcCtD
Fluoxetine—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000345	0.00121	CcSEcCtD
Fluoxetine—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000345	0.00121	CcSEcCtD
Fluoxetine—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00121	CcSEcCtD
Fluoxetine—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000344	0.00121	CcSEcCtD
Fluoxetine—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000343	0.0012	CcSEcCtD
Fluoxetine—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000343	0.0012	CcSEcCtD
Fluoxetine—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000341	0.0012	CcSEcCtD
Fluoxetine—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000341	0.0012	CcSEcCtD
Fluoxetine—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00034	0.00119	CcSEcCtD
Fluoxetine—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000339	0.00119	CcSEcCtD
Fluoxetine—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000339	0.00119	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000337	0.00119	CcSEcCtD
Fluoxetine—Fatigue—Colchicine—primary biliary cirrhosis	0.000337	0.00118	CcSEcCtD
Fluoxetine—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00118	CcSEcCtD
Fluoxetine—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000335	0.00118	CcSEcCtD
Fluoxetine—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00115	CcSEcCtD
Fluoxetine—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000328	0.00115	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.00032	0.00112	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.00032	0.00112	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000319	0.00112	CcSEcCtD
Fluoxetine—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00112	CcSEcCtD
Fluoxetine—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00112	CcSEcCtD
Fluoxetine—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000315	0.00111	CcSEcCtD
Fluoxetine—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000315	0.00111	CcSEcCtD
Fluoxetine—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000313	0.0011	CcSEcCtD
Fluoxetine—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000313	0.0011	CcSEcCtD
Fluoxetine—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000312	0.0011	CcSEcCtD
Fluoxetine—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000312	0.0011	CcSEcCtD
Fluoxetine—Urticaria—Colchicine—primary biliary cirrhosis	0.00031	0.00109	CcSEcCtD
Fluoxetine—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000309	0.00109	CcSEcCtD
Fluoxetine—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000309	0.00109	CcSEcCtD
Fluoxetine—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000309	0.00109	CcSEcCtD
Fluoxetine—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00107	CcSEcCtD
Fluoxetine—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00107	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00107	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00107	CcSEcCtD
Fluoxetine—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00106	CcSEcCtD
Fluoxetine—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00106	CcSEcCtD
Fluoxetine—CYP1A2—liver—primary biliary cirrhosis	0.000301	0.0196	CbGeAlD
Fluoxetine—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00106	CcSEcCtD
Fluoxetine—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00106	CcSEcCtD
Fluoxetine—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00106	CcSEcCtD
Fluoxetine—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00106	CcSEcCtD
Fluoxetine—CYP3A5—liver—primary biliary cirrhosis	0.00029	0.0189	CbGeAlD
Fluoxetine—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00102	CcSEcCtD
Fluoxetine—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000289	0.00102	CcSEcCtD
Fluoxetine—CYP2B6—liver—primary biliary cirrhosis	0.000288	0.0188	CbGeAlD
Fluoxetine—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000288	0.00101	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00101	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00101	CcSEcCtD
Fluoxetine—CYP2C9—liver—primary biliary cirrhosis	0.000285	0.0186	CbGeAlD
Fluoxetine—Asthenia—Colchicine—primary biliary cirrhosis	0.00028	0.000985	CcSEcCtD
Fluoxetine—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000279	0.00098	CcSEcCtD
Fluoxetine—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000279	0.00098	CcSEcCtD
Fluoxetine—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000278	0.000975	CcSEcCtD
Fluoxetine—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000278	0.000975	CcSEcCtD
Fluoxetine—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000278	0.000975	CcSEcCtD
Fluoxetine—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000278	0.000975	CcSEcCtD
Fluoxetine—ABCB1—epithelium—primary biliary cirrhosis	0.000272	0.0177	CbGeAlD
Fluoxetine—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000267	0.00094	CcSEcCtD
Fluoxetine—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000259	0.000909	CcSEcCtD
Fluoxetine—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000259	0.000909	CcSEcCtD
Fluoxetine—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000252	0.000885	CcSEcCtD
Fluoxetine—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000252	0.000885	CcSEcCtD
Fluoxetine—Vomiting—Colchicine—primary biliary cirrhosis	0.000248	0.000873	CcSEcCtD
Fluoxetine—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000248	0.000873	CcSEcCtD
Fluoxetine—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000248	0.000873	CcSEcCtD
Fluoxetine—Rash—Colchicine—primary biliary cirrhosis	0.000246	0.000866	CcSEcCtD
Fluoxetine—Dermatitis—Colchicine—primary biliary cirrhosis	0.000246	0.000865	CcSEcCtD
Fluoxetine—Headache—Colchicine—primary biliary cirrhosis	0.000245	0.00086	CcSEcCtD
Fluoxetine—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.000844	CcSEcCtD
Fluoxetine—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.000844	CcSEcCtD
Fluoxetine—HTR2A—liver—primary biliary cirrhosis	0.000235	0.0153	CbGeAlD
Fluoxetine—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000232	0.000816	CcSEcCtD
Fluoxetine—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000232	0.000816	CcSEcCtD
Fluoxetine—Nausea—Colchicine—primary biliary cirrhosis	0.000232	0.000816	CcSEcCtD
Fluoxetine—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000223	0.000785	CcSEcCtD
Fluoxetine—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000223	0.000785	CcSEcCtD
Fluoxetine—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000221	0.000778	CcSEcCtD
Fluoxetine—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000221	0.000778	CcSEcCtD
Fluoxetine—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000221	0.000777	CcSEcCtD
Fluoxetine—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000221	0.000777	CcSEcCtD
Fluoxetine—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.000773	CcSEcCtD
Fluoxetine—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.000773	CcSEcCtD
Fluoxetine—CYP3A4—liver—primary biliary cirrhosis	0.000218	0.0142	CbGeAlD
Fluoxetine—CYP2D6—liver—primary biliary cirrhosis	0.000214	0.014	CbGeAlD
Fluoxetine—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000209	0.000733	CcSEcCtD
Fluoxetine—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000209	0.000733	CcSEcCtD
Fluoxetine—ABCB1—liver—primary biliary cirrhosis	0.000154	0.01	CbGeAlD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	6.51e-05	0.00169	CbGpPWpGaD
Fluoxetine—ALB—Vitamin B12 Metabolism—NFKB1—primary biliary cirrhosis	6.43e-05	0.00167	CbGpPWpGaD
Fluoxetine—SLC6A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	6.41e-05	0.00167	CbGpPWpGaD
Fluoxetine—ALB—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	6.34e-05	0.00165	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	6.31e-05	0.00164	CbGpPWpGaD
Fluoxetine—HTR2C—G alpha (q) signalling events—AGT—primary biliary cirrhosis	6.26e-05	0.00163	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—primary biliary cirrhosis	6.16e-05	0.0016	CbGpPWpGaD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	6.08e-05	0.00158	CbGpPWpGaD
Fluoxetine—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	6.04e-05	0.00157	CbGpPWpGaD
Fluoxetine—SLC6A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	5.96e-05	0.00155	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	5.76e-05	0.0015	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	5.64e-05	0.00147	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	5.6e-05	0.00146	CbGpPWpGaD
Fluoxetine—HTR2A—G alpha (q) signalling events—AGT—primary biliary cirrhosis	5.44e-05	0.00141	CbGpPWpGaD
Fluoxetine—CYP2C19—Biological oxidations—GGT1—primary biliary cirrhosis	5.4e-05	0.0014	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	5.24e-05	0.00136	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—NFKB1—primary biliary cirrhosis	5.23e-05	0.00136	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	5.22e-05	0.00136	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	5.06e-05	0.00132	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—primary biliary cirrhosis	5e-05	0.0013	CbGpPWpGaD
Fluoxetine—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	4.97e-05	0.00129	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	4.96e-05	0.00129	CbGpPWpGaD
Fluoxetine—CYP2C9—Biological oxidations—GGT1—primary biliary cirrhosis	4.93e-05	0.00128	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—LBR—primary biliary cirrhosis	4.92e-05	0.00128	CbGpPWpGaD
Fluoxetine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	4.88e-05	0.00127	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—primary biliary cirrhosis	4.86e-05	0.00126	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—LBR—primary biliary cirrhosis	4.81e-05	0.00125	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CXCR5—primary biliary cirrhosis	4.76e-05	0.00124	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	4.76e-05	0.00124	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	4.61e-05	0.0012	CbGpPWpGaD
Fluoxetine—SLC6A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	4.58e-05	0.00119	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCR5—primary biliary cirrhosis	4.55e-05	0.00118	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—CXCL10—primary biliary cirrhosis	4.38e-05	0.00114	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CXCL9—primary biliary cirrhosis	4.32e-05	0.00112	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—primary biliary cirrhosis	4.3e-05	0.00112	CbGpPWpGaD
Fluoxetine—CYP1A2—Biological oxidations—GGT1—primary biliary cirrhosis	4.21e-05	0.00109	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	4.19e-05	0.00109	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	4.16e-05	0.00108	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	4.15e-05	0.00108	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—LBR—primary biliary cirrhosis	4.14e-05	0.00108	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCR5—primary biliary cirrhosis	4.13e-05	0.00107	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCL9—primary biliary cirrhosis	4.13e-05	0.00107	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	3.94e-05	0.00103	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CXCL10—primary biliary cirrhosis	3.81e-05	0.00099	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—CCL5—primary biliary cirrhosis	3.77e-05	0.000981	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCL9—primary biliary cirrhosis	3.75e-05	0.000975	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—LBR—primary biliary cirrhosis	3.72e-05	0.000967	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	3.67e-05	0.000955	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	3.66e-05	0.000952	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—primary biliary cirrhosis	3.64e-05	0.000945	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—LBR—primary biliary cirrhosis	3.63e-05	0.000944	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—primary biliary cirrhosis	3.6e-05	0.000936	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—OGDH—primary biliary cirrhosis	3.56e-05	0.000925	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	3.52e-05	0.000916	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—OGDH—primary biliary cirrhosis	3.48e-05	0.000904	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	3.42e-05	0.000889	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—LBR—primary biliary cirrhosis	3.39e-05	0.000882	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CCL5—primary biliary cirrhosis	3.28e-05	0.000852	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	3.25e-05	0.000845	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	3.22e-05	0.000837	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	3.22e-05	0.000837	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PDHX—primary biliary cirrhosis	3.17e-05	0.000825	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—AGT—primary biliary cirrhosis	3.16e-05	0.000821	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PDHX—primary biliary cirrhosis	3.1e-05	0.000806	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	3.09e-05	0.000802	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—OGDH—primary biliary cirrhosis	3e-05	0.000779	CbGpPWpGaD
Fluoxetine—ALB—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.99e-05	0.000779	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—DLAT—primary biliary cirrhosis	2.98e-05	0.000775	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ABCB4—primary biliary cirrhosis	2.98e-05	0.000775	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CDH5—primary biliary cirrhosis	2.92e-05	0.000759	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—DLAT—primary biliary cirrhosis	2.92e-05	0.000758	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ABCB4—primary biliary cirrhosis	2.92e-05	0.000758	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	2.9e-05	0.000754	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.82e-05	0.000734	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCR5—primary biliary cirrhosis	2.81e-05	0.000731	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—AGT—primary biliary cirrhosis	2.74e-05	0.000713	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.7e-05	0.000703	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—OGDH—primary biliary cirrhosis	2.69e-05	0.000699	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PDHX—primary biliary cirrhosis	2.67e-05	0.000694	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	2.62e-05	0.000682	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.62e-05	0.000682	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.55e-05	0.000663	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CDH5—primary biliary cirrhosis	2.53e-05	0.000659	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ABCB4—primary biliary cirrhosis	2.51e-05	0.000653	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—DLAT—primary biliary cirrhosis	2.51e-05	0.000653	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	2.48e-05	0.000644	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	2.47e-05	0.000643	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	2.45e-05	0.000638	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCR5—primary biliary cirrhosis	2.44e-05	0.000634	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.43e-05	0.000631	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PDHX—primary biliary cirrhosis	2.4e-05	0.000623	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ELMO1—primary biliary cirrhosis	2.36e-05	0.000614	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	2.34e-05	0.000608	CbGpPWpGaD
Fluoxetine—SLC6A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.33e-05	0.000605	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.31e-05	0.000601	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	2.25e-05	0.000586	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	2.25e-05	0.000586	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CXCL10—primary biliary cirrhosis	2.25e-05	0.000585	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	2.24e-05	0.000582	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.22e-05	0.000576	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.21e-05	0.000575	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	2.2e-05	0.000573	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	2.2e-05	0.000572	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	2.2e-05	0.000572	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	2.19e-05	0.000568	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CXCL10—primary biliary cirrhosis	2.15e-05	0.000559	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CCL5—primary biliary cirrhosis	2.13e-05	0.000554	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	2.1e-05	0.000545	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.08e-05	0.00054	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	2.07e-05	0.000539	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	2.07e-05	0.000539	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.06e-05	0.000535	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	2.05e-05	0.000534	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	2.05e-05	0.000534	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—MMP3—primary biliary cirrhosis	2.05e-05	0.000533	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ELMO1—primary biliary cirrhosis	2.05e-05	0.000533	CbGpPWpGaD
Fluoxetine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	1.96e-05	0.000509	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.95e-05	0.000508	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.94e-05	0.000503	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.89e-05	0.000492	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.89e-05	0.000491	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	1.87e-05	0.000486	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CCL5—primary biliary cirrhosis	1.85e-05	0.000481	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.85e-05	0.00048	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—NUP210—primary biliary cirrhosis	1.79e-05	0.000466	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—AGT—primary biliary cirrhosis	1.78e-05	0.000464	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.78e-05	0.000463	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	1.76e-05	0.000457	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	1.76e-05	0.000457	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	1.75e-05	0.000455	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.68e-05	0.000438	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.68e-05	0.000437	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ABCG2—primary biliary cirrhosis	1.67e-05	0.000433	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	1.63e-05	0.000423	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—AGT—primary biliary cirrhosis	1.62e-05	0.000421	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.62e-05	0.00042	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.62e-05	0.00042	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—NOS2—primary biliary cirrhosis	1.61e-05	0.000418	CbGpPWpGaD
Fluoxetine—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.6e-05	0.000417	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—AGT—primary biliary cirrhosis	1.55e-05	0.000403	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—NUP210—primary biliary cirrhosis	1.51e-05	0.000392	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.44e-05	0.000375	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.44e-05	0.000374	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.44e-05	0.000374	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—CTGF—primary biliary cirrhosis	1.43e-05	0.000372	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GOT2—primary biliary cirrhosis	1.42e-05	0.000368	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—AGT—primary biliary cirrhosis	1.41e-05	0.000366	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ABCG2—primary biliary cirrhosis	1.4e-05	0.000365	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	1.4e-05	0.000363	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	1.38e-05	0.00036	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.36e-05	0.000352	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.36e-05	0.000352	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	1.35e-05	0.000352	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.33e-05	0.000346	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	1.32e-05	0.000344	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.31e-05	0.000341	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	1.26e-05	0.000327	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	1.25e-05	0.000324	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	1.23e-05	0.000321	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	1.23e-05	0.00032	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GGT1—primary biliary cirrhosis	1.22e-05	0.000318	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—GOT1—primary biliary cirrhosis	1.22e-05	0.000318	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MMP3—primary biliary cirrhosis	1.21e-05	0.000315	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.21e-05	0.000315	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—CTGF—primary biliary cirrhosis	1.2e-05	0.000313	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	1.2e-05	0.000311	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	1.2e-05	0.000311	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GOT2—primary biliary cirrhosis	1.19e-05	0.00031	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	1.16e-05	0.000301	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.15e-05	0.0003	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	1.15e-05	0.000298	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCL5—primary biliary cirrhosis	1.14e-05	0.000297	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.12e-05	0.000291	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.11e-05	0.000288	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.1e-05	0.000287	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—PPARGC1A—primary biliary cirrhosis	1.09e-05	0.000283	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	1.08e-05	0.000281	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	1.07e-05	0.000278	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	1.06e-05	0.000277	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	1.06e-05	0.000274	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	1.05e-05	0.000274	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MMP3—primary biliary cirrhosis	1.05e-05	0.000274	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.05e-05	0.000274	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	1.05e-05	0.000272	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GGT1—primary biliary cirrhosis	1.03e-05	0.000268	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—GOT1—primary biliary cirrhosis	1.03e-05	0.000268	CbGpPWpGaD
Fluoxetine—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.02e-05	0.000266	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.01e-05	0.000262	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	9.94e-06	0.000258	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCL5—primary biliary cirrhosis	9.93e-06	0.000258	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	9.85e-06	0.000256	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	9.85e-06	0.000256	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	9.81e-06	0.000255	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	9.76e-06	0.000254	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	9.63e-06	0.00025	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HIF1A—primary biliary cirrhosis	9.61e-06	0.00025	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—AGT—primary biliary cirrhosis	9.57e-06	0.000249	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	9.24e-06	0.00024	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	9.24e-06	0.00024	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	9.16e-06	0.000238	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	9.02e-06	0.000235	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	9.02e-06	0.000235	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	8.6e-06	0.000224	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	8.5e-06	0.000221	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	8.5e-06	0.000221	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CD80—primary biliary cirrhosis	8.48e-06	0.00022	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—AGT—primary biliary cirrhosis	8.48e-06	0.00022	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	8.43e-06	0.000219	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	8.43e-06	0.000219	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	8.42e-06	0.000219	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	8.34e-06	0.000217	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HIF1A—primary biliary cirrhosis	8.34e-06	0.000217	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—AGT—primary biliary cirrhosis	8.31e-06	0.000216	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	8.29e-06	0.000215	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	8.22e-06	0.000214	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	8.14e-06	0.000212	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	8.03e-06	0.000209	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	7.57e-06	0.000197	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	7.56e-06	0.000197	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	7.5e-06	0.000195	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CD80—primary biliary cirrhosis	7.36e-06	0.000191	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	7.2e-06	0.000187	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	7.2e-06	0.000187	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—TYK2—primary biliary cirrhosis	7.16e-06	0.000186	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—AGT—primary biliary cirrhosis	7.14e-06	0.000186	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ALB—primary biliary cirrhosis	6.51e-06	0.000169	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	6.5e-06	0.000169	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	6.44e-06	0.000167	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	6.41e-06	0.000167	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	6.41e-06	0.000167	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	6.36e-06	0.000165	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—AGT—primary biliary cirrhosis	6.25e-06	0.000163	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—TYK2—primary biliary cirrhosis	6.21e-06	0.000162	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	5.89e-06	0.000153	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	5.84e-06	0.000152	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—MMP9—primary biliary cirrhosis	5.64e-06	0.000147	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.58e-06	0.000145	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	5.56e-06	0.000144	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	5.56e-06	0.000144	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	4.99e-06	0.00013	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	4.95e-06	0.000129	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	4.92e-06	0.000128	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—MMP9—primary biliary cirrhosis	4.89e-06	0.000127	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.84e-06	0.000126	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ALB—primary biliary cirrhosis	4.8e-06	0.000125	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	4.52e-06	0.000118	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	4.48e-06	0.000117	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	3.85e-06	0.0001	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	3.83e-06	9.96e-05	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	2.96e-06	7.69e-05	CbGpPWpGaD
